The hashtag for the 2026 event is #CVFORUM26.
Request an invite if you are interested in joining us for the 2026 conference.

Leaders shaping the 2026 agenda

Naomi Aoki, SVP, Head of Investor Relations & Corporate Communications, Spur Therapeutics
Katrine Bosley, Chairman, Arrakis Therapeutics
Keting Chu, PhD, Founder, Chairman & CEO, Bluejay Therapeutics
Rena Denoncourt, Chief Operating Officer, Corsera Health
Steve Dickman, CEO, CBT Advisors
David Ewing Duncan, Co-Founder, Curator and CEO, Arc Fusion
Geoffrey Duyk, MD, PhD, CEO & Co-Founder, Grove BioPharma
Richard Kivel, Managing Director, GrayBella Capital
Bruce Leuchter, MD, President & CEO, Neurvati Neurosciences
Liz Leveille, VP, Business Dev. & Licensing, Head, Boston & European Innovation Hubs & Discovery Transactions, Merck
Brad Loncar, Founder, BioTech TV
Karla MacDonald, Chief Corporate Affairs Officer, Entrada Therapeutics
Ivana Magovcevic-Liebisch, PhD, CEO & President, Draig Therapeutics
Sarah Maxfield, Executive Vice President, BD at Cyprotex & Evotec Development, Evotec
Jodie Morrison, CEO, Q32 Bio; Board Member; Venture Advisor, Atlas Venture
Vinit Nijhawan, Managing Director, MassVentures
Catherine Pagliarulo, Vice President, Alexandria Venture Investments
Rosemary Reilly, Partner, Sidley Austin LLP
Mark Rus, CEO, Delix Therapeutics
Alison Taunton-Rigby OBE, PhD, Independent Director, CEO, and Entrepreneur, Life Science & Healthcare Organizations
Luke Timmerman, Founder & Editor, Timmerman Report
Heather Turner, CEO, LB Pharmaceuticals
Ramani Varanasi, CEO, LIBRIS Innovations
Karen Weintraub, Reporter/Editor, USA Today